Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Holdings

4,830.23
+16.310.34%
Number of Gainers:20
Number of Losers:43
Number of Flat:2
PE:- -
High:4,856.87
Open:4,813.19
Low:4,802.14
Close:4,813.92
Volume:296.86M
Turnover:28.02B
Market Cap:8.62T
Float Cap:8.18T

Loading ...

Nkarta to Present Initial Phase 1/2 Autoimmune Data for CAR-NK Therapy Nkx019 at ACR Convergence 2026

Reuters
·
Sep 08

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

THOMSON REUTERS
·
Sep 08

Odds ‘4 to 1’ against Apple as Ternus takes helm, says Needham

TIPRANKS
·
Sep 08

UiPath initiated with a Buy at Citi

TIPRANKS
·
Sep 08

MoffettNathanson Adjusts Price Target on Apple to $304 From $270, Keeps Neutral Rating

MT Newswires Live
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 08

Sarepta, Dyne Sink After Novartis Muscle Disorder Trial Failure

Reuters
·
Sep 08

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Tuesday; Bloom Energy, Oracle to Open Higher

MT Newswires Live
·
Sep 08

Beam Therapeutics’ BEAM-302 shows efficacy in Phase 1/2 AATD trial

TIPRANKS
·
Sep 08

Sarepta Therapeutics Down 15.6%, Dyne Therapeutics Down 29%

THOMSON REUTERS
·
Sep 08

Shares of Some Drug Developers Fall Premarket After Novartis Late-Stage Muscle Disorder Trial Fails

THOMSON REUTERS
·
Sep 08

Bilibili Issues 182,620 Class Z Shares on Stock Option Exercises Under 2018 Incentive Plan

Reuters
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of Beam-302 in Alpha-1 Antitrypsin Deficiency (Aatd) at the European Respiratory Society (Ers) Congress 2026

THOMSON REUTERS
·
Sep 08

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Sep 08

UiPath, Inc. : Barclays Raises Target Price to $17 from $14

THOMSON REUTERS
·
Sep 08

Baird Adjusts Price Target on Airbnb to $200 From $175, Maintains Outperform Rating

MT Newswires Live
·
Sep 08

AI is Disrupting Software Companies, but not as Fast as Many Feared - Heard on the Street

Dow Jones
·
Sep 08

TSMC and Samsung Confirm Adoption of ASML's Cutting-Edge Lithography Systems

Deep News
·
Sep 08

Apple Stock (AAPL) Falls Ahead of Flagship Sept. 9 Event — Here’s What Analysts Expect

TIPRANKS
·
Sep 08

ASML Set to Benefit from TSMC Use of Advanced Chip-Making Technology

Dow Jones
·
Sep 08